Author

G. Dayer

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Organism:human· 2 Assay:protein structure· 2 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Research Focus:drug response / drug discovery· 1 Research Focus:protein folding & dynamics· 1

Frequent Co-Authors

I. Zehbe· 2 shared M. Togtema· 2 shared A. Faulkner· 1 shared G. Hussack· 1 shared J. Tanha· 1 shared M. Teghtmeyer· 1 shared S. Raphael· 1 shared T. Talwar· 1 shared

Activity by Year

2018-2022 · peak 1/yr

Co-Author Collaboration Network

8 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

I. Zehbe

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Targeting the Human Papillomavirus 16 E6 Oncoprotein with Antibodies

G. Dayer, A. Faulkner, T. Talwar, M. Togtema, I. Zehbe

This paper reviews anti-E6 antibodies and presents new Camelidae-derived single-domain antibodies that bind endogenous E6 but do not induce apoptosis.

bioRxiv · Oct 21, 2022 · PreprintCancer Biology

Single-domain antibodies represent novel alternatives to monoclonal antibodies as targeting agents against the human papillomavirus 16 E6 protein

M. Togtema, G. Hussack, G. Dayer, M. Teghtmeyer, S. Raphael, J. Tanha, I. Zehbe

This study identifies VHHs that bind HPV16 E6 protein with nanomolar affinity, offering potential as novel targeting agents for HPV16-related cancers.

bioRxiv · Aug 9, 2018Cancer Biology